Cholera Confusion, circa 1832

As cholera first tore through the Europe in the mid-19th century, people tried anything to prevent the deadly disease. Then science stepped in.

Written byDan Cossins
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WARDING OFF CHOLERA: Printed in Nuremberg, Germany, around 1832, this depiction of a woman’s attempts to repel cholera satirizes the abundance of dubious advice about prevention. Little was known about the disease when it first arrived in Europe, but by the end of the 19th century, physician-scientists had identified the culprit bacterium, rendering homemade prevention methods obsolete.THE FRANCIS A. COUNTWAY LIBRARY OF MEDICINE, HARVARD MEDICAL LIBRARYAll the way from the Ganges River delta in India, an unwelcome visitor arrived in Europe in 1831. Its victims suffered violent cramps, vomiting, and diarrhea, along with dehydration so rapid and severe that their skin was rendered a deathly blue. Many died within hours of the first symptoms.

Cholera was one of the most devastating diseases to hit Europe in the 19th century, with a series of epidemics taking hundreds of thousands of lives. And because its cause was a mystery, people were prepared to take any measure to keep it at bay. “They tried all manner of things,” says Christopher Hamlin, a science historian at the University of Notre Dame in Indiana and author of Cholera: The Biography.

Leading theories at the time held that the disease was caught through exposure to foul or filthy air, so measures designed to repel cholera by purifying the air were particularly common, as depicted in this satirical cartoon of a woman extravagantly equipped with chlorinated lime, garlic, various herbs, and vinegar bags. “Anything that tended ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies